Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Revenue
€ 10.7 million
▲ 1% vs 2024
Profit
Caution€ -231,419
▲ 72% vs 2024
Debts
Low€ 2.4 million
▼ 28% vs 2024
INFINITY PHARMA from Nazareth-De Pinte, company number BE0416616681, closed financial year 2025 with a result of € -231,419 after tax. For that financial year INFINITY PHARMA recorded revenue of € 10.7 million and equity of € 16.4 million. Compared with financial year 2024, the result moved from € -822,517 to € -231,419. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.
What happened at INFINITY PHARMA?
What happened at INFINITY PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Rafael PADILLA stepped down as director. NBB
- Cornelia DE JONG stepped down as director. NBB
- Céline Caveye stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 231,419. Source: NBB ↗
- Johan Verlinden stepped down as director. NBB
- Rafael PADILLA became a director. NBB
- Cornelia DE JONG became a director. NBB
- Céline Caveye became a director. NBB
In short
From € 6.4 million loss in 2021 to € 231,419 loss in 2025.
Paid € 7,541 in corporate taxes since 2021.
Paid out € 25 million in dividends to the owners in total.
Pays suppliers within 83 days on average.
A new publication or filing at INFINITY PHARMA? We notify you, reason included.
Follow INFINITY PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of FAGRON COMPOUNDING SERVICES, 100% of FAGRON BELGIUM and ABC Dental and pharmaceutical consultancy itself.
Directors
According to the 2025 annual accounts
Rafael PADILLA
Director
Also active at: FAGRON BELGIUM, ABC DENTAL AND PHARMACEUTICAL CONSULTANCY, FAGRON CAPITAL +2 more
since 2023 · until 2028
Céline Caveye
Director
since 2021 · until 2027
since 2022 · until 2028
Johan Verlinden
Director
since 2021 · until 2026
Establishments
Establishment units
Physical locations of this company
Venecoweg 20A
9810 Nazareth-De Pinte
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
FASTLY - Fastly, Inc., US
Website info
Features
Security
Network
Details
- Company number
- 0416.616.681
- VAT number
- BE 0416.616.681
- Registered office
- Venecoweg 20A, 9810 Nazareth-De Pinte
- Names & denominations
- INFINITY PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 8 December 1976
- Peppol
- Active · Active since 1 Oct 2025
- Contact
- pharma-pack.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten